Free Webex Call
The Peanut Allergy Treatment Market was valued at USD 0.59 Billion in 2024, and is expected to reach USD 1.21 Billion by 2030, rising at a CAGR of 12.84%. The rising awareness about peanut allergies, coupled with technological advancements, is driving significant growth in this market. Peanut allergy is a life-threatening condition that continues to affect millions globally, prompting a surge in demand for effective treatment options. Improved scientific understanding of allergy mechanisms has enabled the development of targeted therapies such as allergen-specific immunotherapy and gene-based treatments. The market has garnered attention from pharmaceutical companies and research organizations that are investing extensively in R&D to capitalize on the growing need for innovative and life-saving treatment solutions. Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Key Market Drivers
Rising Prevalence of Peanut Allergies
The global rise in peanut allergy cases is a major factor accelerating growth in the peanut allergy treatment market. In Western countries, incidence rates have risen sharply over the last two decades. For example, the prevalence among U.S. children grew from 0.4% in 1997 to 1.4% by 2008, while the UK saw childhood food allergies triple from 1.2% to 4% between 2008 and 2018.This increase has intensified the demand for effective therapeutic solutions. Health authorities such as the CDC have flagged food allergies as a mounting public health concern, advocating for improved diagnostic and treatment frameworks. Parental concern and awareness regarding severe allergic reactions have spurred a push for more advanced interventions. As a result, pharmaceutical companies are intensifying efforts to develop treatments like biologics and immunotherapies to address this critical health issue, further propelling market expansion.
Key Market Challenges
High Cost of Treatment
The high cost associated with peanut allergy therapies remains a major challenge for market penetration and equitable access. Treatments such as immunotherapy and biologics involve high expenses related to drug formulation, administration, monitoring, and managing side effects. These costs may be prohibitive, especially in areas with limited insurance coverage or healthcare funding. Coverage discrepancies in insurance plans exacerbate affordability issues, discouraging patients from pursuing potentially effective care. Public healthcare systems also face budgetary pressures due to the high treatment costs. Overcoming this barrier requires cooperation among pharmaceutical companies, insurers, and government bodies. Implementing measures such as value-based pricing, enhanced insurance reimbursement, and patient support programs is essential to broaden treatment accessibility.Key Market Players
- Vedanta Biosciences, Inc.
- Alladapt Immunotherapeutics, Inc.
- Regeneron Pharmaceuticals Inc.
- Aravax Pty Ltd
- Teva Pharmaceutical Industries Limited
- Prota Therapeutics Pty Ltd.
- Aimmune Therapeutics, Inc. (Nestle)
- DBV Technologies SA
- Sanofi SA
- Mylan N.V.
Report Scope:
In this report, the Global Peanut Allergy Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:Peanut Allergy Treatment Market, By Drug Class:
- Antihistamines
- Epinephrine
- Immunotherapies
- Others
Peanut Allergy Treatment Market, By Route of Administration:
- Oral
- Intravenous
- Others
Peanut Allergy Treatment Market, By Distribution Channel:
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
Peanut Allergy Treatment Market, By Region:
- North America
- United States
- Mexico
- Canada
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia-Pacific
- China
- India
- South Korea
- Japan
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Peanut Allergy Treatment Market.Available Customizations:
With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.Company Information
- Detailed analysis and profiling of additional market players (up to five).
This product will be delivered within 1-3 business days.
Table of Contents
1. Product Overview
2. Research Methodology
3. Executive Summary
5. Global Peanut Allergy Treatment Market Outlook
6. North America Peanut Allergy Treatment Market Outlook
7. Europe Peanut Allergy Treatment Market Outlook
8. Asia-Pacific Peanut Allergy Treatment Market Outlook
9. South America Peanut Allergy Treatment Market Outlook
10. Middle East and Africa Peanut Allergy Treatment Market Outlook
11. Market Dynamics
12. Market Trends & Developments
14. Porter’s Five Forces Analysis
15. Competitive Landscape
Companies Mentioned
- Vedanta Biosciences, Inc.
- Alladapt Immunotherapeutics, Inc.
- Regeneron Pharmaceuticals Inc.
- Aravax Pty Ltd
- Teva Pharmaceutical Industries Limited
- Prota Therapeutics Pty Ltd.
- Aimmune Therapeutics, Inc. (Nestle)
- DBV Technologies SA
- Sanofi SA
- Mylan N.V.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 180 |
Published | May 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 0.59 Billion |
Forecasted Market Value ( USD | $ 1.21 Billion |
Compound Annual Growth Rate | 12.8% |
Regions Covered | Global |
No. of Companies Mentioned | 10 |